Finance

Lists
CLN:WSE
Celon Pharma SA
18,68 PLN
-0,53%
(-0,10) 1D
8 қаз., 17:02:24 GMT+2  ·   PLN
All symbols
SymbolPriceChange% Change
Generating top insights for CLN...
Open
18,82 PLN
High
18,82 PLN
Low
18,60 PLN
Mkt. cap
1,01 млрд
Avg. vol.
15,47 мың
Volume
9,28 мың
P/E ratio
9,10
52-wk high
23,50 PLN
52-wk low
18,00 PLN
EPS
2,05 PLN
Shares outstanding
53,91 млн
No. of employees
560
Open
18,82 PLN
High
18,82 PLN
Low
18,60 PLN
Mkt. cap
1,01 млрд
Avg. vol.
15,47 мың
Volume
9,28 мың
P/E ratio
9,10
52-wk high
23,50 PLN
52-wk low
18,00 PLN
EPS
2,05 PLN
Shares outstanding
53,91 млн
No. of employees
560
News stories
From web sources and news partners
About Celon Pharma SA
CEO-
Employees560
Founded2002
Headquarters-
SectorPharmaceutical industry
Last report
2026 ж. 16 қыр.
Fiscal period
Q2 2026
- / -
Revenue / Est. (PLN)
55,57 млн / 60,50 млн
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in PLN
Loading Previous Earnings...
Revenue
Net income
All values in PLN
2025 ж. қыр.
2025 ж. жел.
2026 ж. нау.
2026 ж. мау.
Revenue
71,13 млн
66,67 млн
65,26 млн
55,57 млн
Cost of goods sold
16,83 млн
11,54 млн
16,70 млн
14,92 млн
Cost of revenue
16,83 млн
11,54 млн
16,70 млн
14,92 млн
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
33,02 млн
35,44 млн
36,08 млн
38,62 млн
Operating expense
46,24 млн
52,60 млн
54,54 млн
50,11 млн
Total operating expenses
63,07 млн
64,14 млн
71,23 млн
65,04 млн
Operating income
8,06 млн
2,53 млн
-5,98 млн
-9,46 млн
Other non operating income
-30,00 мың
-250,00 м.
169,05 млн
3,48 млн
EBT including unusual items
-2,77 млн
-6,57 млн
160,34 млн
-7,38 млн
EBT excluding unusual items
-2,77 млн
-6,57 млн
160,34 млн
-7,38 млн
Income tax expense
-6,43 млн
18,33 млн
1,70 млн
23,21 млн
Effective tax rate
232,29%
-279,14%
1,06%
-314,48%
Other operating expenses
2,20 млн
6,37 млн
7,33 млн
1,36 млн
Net income
3,66 млн
-24,90 млн
158,64 млн
-30,59 млн
Net profit margin
5,15%
-37,35%
243,09%
-55,05%
Earnings per share
-
-
-
-
Interest and investment income
-
149,00 м.
151,00 м.
151,00 м.
Interest expense
-
-341,00 м.
-915,00 м.
-1,55 млн
Net interest expenses
-
-192,00 м.
-764,00 м.
-1,40 млн
Depreciation and amortization charges
11,01 млн
10,78 млн
11,13 млн
10,13 млн
EBITDA
16,34 млн
11,40 млн
3,44 млн
-748,00 м.
Gain or loss from assets sale
-170,00 м.
-2,91 млн
-569,00 м.
716,00 м.
AI content may include mistakes. Learn more
Google қолданбалары